Rani E. George

9.3k citations

55 papers · 4.9k indexed · 3 hit papers · h-index 30

Impact in

Neurology top 0.5%
- Neuroblastoma Research and Treatments
Cancer Research top 1%
- Cancer, Hypoxia, and Metabolism

Papers in ⓘ

Neurology 42
- Neuroblastoma Research and Treatments 42
Molecular Biology 30
- Protein Degradation and Inhibitors 9
- Cancer therapeutics and mechanisms 8

Co-authors: Satyaki Sengupta (6 shared papers)A. Thomas Look (9 shared papers)Guo‐Cheng Yuan (5 shared papers)Nathanael S. Gray (11 shared papers)Kwok‐Kin Wong (5 shared papers)Lisa Diller (11 shared papers)Rodney A. Stewart (4 shared papers)Ruben Dries (5 shared papers)
Journals: Journal of Clinical Oncology (5 papers)Clinical Cancer Research (2 papers)Cell Reports (2 papers)Nature (2 papers)Journal of Medicinal Chemistry (2 papers)
Partner nations: United States United Kingdom Netherlands

In The Last Decade

Rani E. George

55 papers receiving 4.8k citations

Hit Papers

align trajectories log scale

Giotto: a toolbox for integrative analysis and visualization of spatial expression data 2021 · 510 citations

Peers

Countries citing papers authored by Rani E. George

Since Specialization

Citations

This map shows the geographic impact of Rani E. George's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rani E. George with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rani E. George more than expected).

Fields of papers citing papers by Rani E. George

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rani E. George. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rani E. George. The network helps show where Rani E. George may publish in the future.

Co-authors

The 25 scholars most cited alongside Rani E. George, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Rani E. George Line = papers co-authored together Rani E. George links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 55 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	mRNA circularization by METTL3–eIF3h enhances translation and promotes oncogenesis Nature ·Junho Choe, Shuibin Lin, Wen Cai Zhang, Qi Liu, Longfei Wang, Julia Ramírez-Moya, Peng Du, Wantae Kim, Shaojun Tang, Piotr Sliz, Pilar Santisteban, Rani E. George, William G. Richards, Kwok‐Kin Wong, Nicolas Locker, Frank J. Slack, Richard I. Gregory Hit paper breakdown →	2018	567
2	Giotto: a toolbox for integrative analysis and visualization of spatial expression data Genome biology ·Ruben Dries, Qian Zhu, Rui Dong, Chee-Huat Linus Eng, Huipeng Li, Kan Liu, Yuntian Fu, Tianxiao Zhao, Arpan Sarkar, Feng Bao, Rani E. George, Nico Pierson, Long Cai, Guo‐Cheng Yuan Hit paper breakdown →	2021	510
3	CDK7 Inhibition Suppresses Super-Enhancer-Linked Oncogenic Transcription in MYCN-Driven Cancer Cell ·Edmond Chipumuro, Eugenio Marco, Camilla L. Christensen, Nicholas Kwiatkowski, Tinghu Zhang, Clark M. Hatheway, Brian J. Abraham, Bandana Sharma, Caleb M. Yeung, Abigail Altabef, Antonio R. Pérez‐Atayde, Kwok‐Kin Wong, Guo‐Cheng Yuan, Nathanael S. Gray, Richard A. Young, Rani E. George Hit paper breakdown →	2014	451
4	The kinesin KIF1Bβ acts downstream from EglN3 to induce apoptosis and is a potential 1p36 tumor suppressor Genes & Development ·Susanne Schlisio, Rajappa S. Kenchappa, Liesbeth C.W. Vredeveld, Rani E. George, Rodney A. Stewart, Heidi Greulich, Kristina Shahriari, Nguyen V. Nguyen, Pascal Pigny, Patricia L. M. Dahia, Scott L. Pomeroy, John M. Maris, A. Thomas Look, Matthew Meyerson, Daniel S. Peeper, Bruce Carter, William G. Kaelin	2008	257
5	TERT rearrangements are frequent in neuroblastoma and identify aggressive tumors Nature Genetics ·Linda J. Valentijn, Jan Köster, Danny A. Zwijnenburg, Nancy E. Hasselt, Peter van Sluis, Richard Volckmann, Max M. van Noesel, Rani E. George, Godelieve A.M. Tytgat, Jan J. Molenaar, Rogier Versteeg	2015	255
6	Activated ALK Collaborates with MYCN in Neuroblastoma Pathogenesis Cancer Cell ·Shizhen Zhu, Jeong-Soo Lee, Feng Guo, Jimann Shin, Antonio R. Pérez‐Atayde, Jeffery L. Kutok, Scott J. Rodig, Donna Neuberg, Daniel Helman, Hui Feng, Rodney A. Stewart, Wenchao Wang, Rani E. George, John P. Kanki, A. Thomas Look	2012	235
7	Super-Enhancer-Driven Transcriptional Dependencies in Cancer Trends in cancer ·Satyaki Sengupta, Rani E. George	2017	230
8	Anaplastic lymphoma kinase: role in cancer pathogenesis and small-molecule inhibitor development for therapy Expert Review of Anticancer Therapy ·Thomas R. Webb, Jake Slavish, Rani E. George, A. Thomas Look, Liquan Xue, Qin Jiang, Xiaoli Cui, Walter B Rentrop, Stephan W. Morris	2009	183
9	CDK12 loss in cancer cells affects DNA damage response genes through premature cleavage and polyadenylation Nature Communications ·Małgorzata Krajewska, Ruben Dries, Andrew V. Grassetti, Sofia Dust, Yang Gao, Hao Huang, Bandana Sharma, Daniel S. Day, Nicholas Kwiatkowski, Monica Pomaville, Oliver Dodd, Edmond Chipumuro, Tinghu Zhang, Arno L. Greenleaf, Guo‐Cheng Yuan, Nathanael S. Gray, Richard A. Young, Matthias Geyer, Scott A. Gerber, Rani E. George	2019	181
10	Chemically Induced Degradation of Anaplastic Lymphoma Kinase (ALK) Journal of Medicinal Chemistry ·Chelsea E. Powell, Yang Gao, Li Tan, Katherine A. Donovan, Radosław P. Nowak, Amanda R. Loehr, Magda Bahcall, Eric S. Fischer, Pasi A. Jänne, Rani E. George, Nathanael S. Gray	2018	156
11	Zebrafish foxd3 is selectively required for neural crest specification, migration and survival Developmental Biology ·Rodney A. Stewart, Brigitte L. Arduini, Stéphane Berghmans, Rani E. George, John P. Kanki, Paul D. Henion, A. Thomas Look	2006	151
12	High-Risk Neuroblastoma Treated With Tandem Autologous Peripheral-Blood Stem Cell–Supported Transplantation: Long-Term Survival Update Journal of Clinical Oncology ·Rani E. George, Shuli Li, Cheryl Medeiros-Nancarrow, Donna Neuberg, Karen Marcus, Robert C. Shamberger, Michael A. Pulsipher, Stephan A. Grupp, Lisa Diller	2006	143
13	Promising Therapeutic Targets in Neuroblastoma Clinical Cancer Research ·Katherine K. Matthay, Rani E. George, Alice L. Yu	2012	141
14	A phase I trial combining decitabine/dendritic cell vaccine targeting MAGE-A1, MAGE-A3 and NY-ESO-1 for children with relapsed or therapy-refractory neuroblastoma and sarcoma Cancer Immunology Immunotherapy ·Deepa Kolaseri Krishnadas, Suzanne Shusterman, Fanqi Bai, Lisa Diller, Janice E. Sullivan, Alexandra Cheerva, Rani E. George, Kenneth G. Lucas	2015	133
15	Neuroblastoma Cells Isolated from Bone Marrow Metastases Contain a Naturally Enriched Tumor-Initiating Cell Cancer Research ·Loen M. Hansford, Amy E. McKee, Libo Zhang, Rani E. George, J. Ted Gerstle, Paul S. Thorner, Kristen M. Smith, A. Thomas Look, Herman Yeger, Freda D. Miller, Meredith S. Irwin, Carol J. Thiele, David R. Kaplan	2007	132
16	Hyperdiploidy Plus Nonamplified MYCN Confers a Favorable Prognosis in Children 12 to 18 Months Old With Disseminated Neuroblastoma: A Pediatric Oncology Group Study Journal of Clinical Oncology ·Rani E. George, Wendy B. London, Susan L. Cohn, John M. Maris, Cynthia S. Kretschmar, Lisa Diller, Garrett M. Brodeur, Robert P. Castleberry, A. Thomas Look	2005	91
17	Genome-Wide Analysis of Neuroblastomas using High-Density Single Nucleotide Polymorphism Arrays PLoS ONE ·Rani E. George, Edward F. Attiyeh, Shuli Li, Lisa A. Moreau, Donna Neuberg, Cheng Li, Edward A. Fox, Matthew Meyerson, Lisa Diller, Paolo Fortina, A. Thomas Look, John M. Maris	2007	82
18	Emerging importance of ALK in neuroblastoma Seminars in Cancer Biology ·Anna M. Azarova, Gargi Gautam, Rani E. George	2011	80
19	BORIS promotes chromatin regulatory interactions in treatment-resistant cancer cells Nature ·David Debruyne, Ruben Dries, Satyaki Sengupta, Davide Seruggia, Yang Gao, Bandana Sharma, Hao Huang, Lisa A. Moreau, Michael McLane, Daniel S. Day, Eugenio Marco, Ting Chen, Nathanael S. Gray, Kwok‐Kin Wong, Stuart H. Orkin, Guo‐Cheng Yuan, Richard A. Young, Rani E. George	2019	74
20	Overcoming Resistance to the THZ Series of Covalent Transcriptional CDK Inhibitors Cell chemical biology ·Yang Gao, Tinghu Zhang, Hideki Terai, Scott B. Ficarro, Nicholas Kwiatkowski, Ming-Feng Hao, Bandana Sharma, Camilla L. Christensen, Edmond Chipumuro, Kwok‐Kin Wong, Jarrod A. Marto, Peter S. Hammerman, Nathanael S. Gray, Rani E. George	2017	56

About Rani E. George

Rani E. George is a scholar working on Neurology, Molecular Biology, Cancer Research, Oncology and Genetics, having authored 55 papers that have together received 4.9k indexed citations. Recurring topics across this work include Neuroblastoma Research and Treatments (42 papers), Cancer, Hypoxia, and Metabolism (15 papers), Protein Degradation and Inhibitors (9 papers), Cancer therapeutics and mechanisms (8 papers), Lung Cancer Research Studies (7 papers), Virus-based gene therapy research (5 papers), Glioma Diagnosis and Treatment (5 papers) and Neuroendocrine Tumor Research Advances (5 papers). The work is most often cited by research in Neurology (1.5k citations), Cancer Research (1.4k citations), Molecular Biology (3.4k citations), Oncology (1.1k citations) and Biophysics (116 citations). Rani E. George has collaborated with scholars based in United States, United Kingdom and Netherlands. Frequent co-authors include Satyaki Sengupta, A. Thomas Look, Guo‐Cheng Yuan, Nathanael S. Gray, Kwok‐Kin Wong, Lisa Diller, Rodney A. Stewart, Ruben Dries, Bandana Sharma and Antonio R. Pérez‐Atayde. Their work appears in journals such as Journal of Clinical Oncology, Clinical Cancer Research, Cell Reports, Nature and Journal of Medicinal Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact